Search for: All records

Recent observations of plasma-activated water (PAW)’s surfactant behavior suggest that the activation of water with non-equilibrium plasma can decrease the surface tension of the water. This suggested change to the surface tension also indicates that the addition of plasma can lead to changes in the physical properties of the water, knowledge of which can expand existing PAW applications and open new ones. While the chemical behavior of PAW has been extensively analyzed, to the best of our knowledge the physical properties of PAW have not been investigated. This study focuses on the need for experimental determination of PAW’s physical properties—namely, surface tension, viscosity, and contact angle. The experimental results of this study show that the addition of plasma lowers the surface tension of water at room temperature, increases the viscosity of water at high temperatures, and lowers the contact angle of droplets on glass surfaces at room temperatures. Potential factors influencing these changes include plasma alteration of the mesoscopic structure of water at low temperatures and plasma additives acting as foreign particles in water at higher temperatures. Ultimately, this investigation demonstrates that the physical properties of water change due to plasma activation, which could lead to potential industrial applications of PAW as a surfactant or as a washing-out and cleaning agent. 

Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic organofluorine surfactants that are resistant to typical methods of degradation. Thermal techniques along with other novel, less energy-intensive techniques are currently being investigated for the treatment of PFAS-contaminated matrices. Non-equilibrium plasma is one technique that has shown promise for the treatment of PFAS-contaminated water. To better tailor non-equilibrium plasma systems for this application, knowledge of the energy required for mineralization, and in turn the roles that plasma reactive species and heat can play in this process, would be useful. In this study, fundamental thermodynamic equations were used to estimate the enthalpies of reaction (480 kJ/mol) and formation (−4640 kJ/mol) of perfluorooctanoic acid (PFOA, a long-chain legacy PFAS) in water. This enthalpy of reaction estimate indicates that plasma reactive species alone cannot catalyze the reaction; because the reaction is endothermic, energy input (e.g., heat) is required. The estimated enthalpies were used with HSC Chemistry software to produce a model of PFOA defluorination in a 100 mg/L aqueous solution as a function of enthalpy. The model indicated that as enthalpy of the reaction system increased, higher PFOA defluorination, and thus a higher extent of mineralization, was achieved. The model results were validated using experimental results from the gliding arc plasmatron (GAP) treatment of PFOA or PFOS-contaminated water using argon and air, separately, as the plasma gas. It was demonstrated that PFOA and PFOS mineralization in both types of plasma required more energy than predicted by thermodynamics, which was anticipated as the model did not take kinetics into account. However, the observed trends were similar to that of the model, especially when argon was used as the plasma gas. Overall, it was demonstrated that while energy input (e.g., heat) was required for the non-equilibrium plasma degradation of PFOA in water, a lower energy barrier was present with plasma treatment compared to conventional thermal treatments, and therefore mineralization was improved. Plasma reactive species, such as hydroxyl radicals (⋅OH) and/or hydrated electrons (e−(aq)), though unable to accelerate an endothermic reaction alone, likely served as catalysts for PFOA mineralization, helping to lower the energy barrier. In this study, the activation energies (Ea) for these species to react with the alpha C–F bond in PFOA were estimated to be roughly 1 eV for hydroxyl radicals and 2 eV for hydrated electrons. 

Plasma's role in healthcare has been steadily gaining recognition, particularly for its capacity to produce reactive species that foster wound healing, combat microbial infections, and augment drug delivery. Despite its promise, implementation of plasma technologies is often impeded by logistical constraints, accessibility issues, and challenges integrating with established medical treatments. In this paper, we describe an innovative solution to deliver the benefits of plasma in healthcare: plasma-activated cream (PAC). PAC offers a versatile lipid-based platform for medical applications that transcends the traditional boundaries of plasma application by its flexible integration into a variety of treatment forms: as a cream base for transdermal applications, oil base for injectables, or incorporation with other biologics and lipid-soluble compounds. In this study, we reveal the novel method of creating PAC by infusing a lipophilic base with plasma-activated species, specifically focusing on nitric oxide (NO) and its related compounds (NOx). By measuring NOx concentrations before and after plasma treatment, we successfully validated the use of gliding-arc plasma to synthesize PAC. The NOx concentration rose from a baseline of 0 mg/L to an average of 2.0 mg/L post-treatment, indicative of successful infusion of plasma-activated species into PAC. This preliminary experiment unveils a novel pathway for incorporating plasma's beneficial effects into a lipid-based cream and shows the potential for PAC to act as NO storage. PAC not only brings forth new possibilities in wound-healing and antimicrobial treatments but also lays the groundwork for further exploration of plasma's role in enhancing drug delivery and NO storage.